The power of randomness is one of the most enduring mysteries of computation. In the last 30+ years, several algorithms have been designed which crucially use randomness and beat their deterministic ...

Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease In this phase II, prospective randomized trial ...

A new ESC/EAS Focused Update to guidelines, about how best to manage lipid levels in patients to reduce cardiovascular risk, ...

Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma The following represents disclosure ...

Patients undergoing cardiac surgery often receive red-cell transfusions, along with the associated risks and costs. Early intraoperative normovolemic hemodilution (i.e., acute normovolemic ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

- In the overall modified intention-to-treat (mITT) population, improvements across all efficacy and secondary endpoints, including 24% reduction in knee pain and 26% improvement in knee function, ...

Twice-yearly subcutaneous lenacapavir has been shown to be efficacious for prevention of human immunodeficiency virus (HIV) infection in cisgender women. The efficacy of lenacapavir for preexposure ...

The Bluetooth Special Interest Group (SIG) has announced Bluetooth Core Specification 6.1, bringing important improvements to the popular wireless communication protocol. One new feature highlighted ...